Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Diet and exercise for preeclampsia prevention in overweight and obese pregnant women: systematic review and meta-analysis.

Syngelaki A, Sequeira Campos M, Roberge S, Andrade W, Nicolaides KH.

J Matern Fetal Neonatal Med. 2018 Sep 6:1-7. doi: 10.1080/14767058.2018.1481037. [Epub ahead of print]

PMID:
29792061
2.

Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.

Incio J, Ligibel JA, McManus DT, Suboj P, Jung K, Kawaguchi K, Pinter M, Babykutty S, Chin SM, Vardam TD, Huang Y, Rahbari NN, Roberge S, Wang D, Gomes-Santos IL, Puchner SB, Schlett CL, Hoffmman U, Ancukiewicz M, Tolaney SM, Krop IE, Duda DG, Boucher Y, Fukumura D, Jain RK.

Sci Transl Med. 2018 Mar 14;10(432). pii: eaag0945. doi: 10.1126/scitranslmed.aag0945.

3.

Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage.

Roberge S, Bujold E, Nicolaides KH.

Am J Obstet Gynecol. 2018 May;218(5):483-489. doi: 10.1016/j.ajog.2017.12.238. Epub 2018 Jan 3. Review.

PMID:
29305829
4.

Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.

Johnsen JM, Fletcher SN, Huston H, Roberge S, Martin BK, Kircher M, Josephson NC, Shendure J, Ruuska S, Koerper MA, Morales J, Pierce GF, Aschman DJ, Konkle BA.

Blood Adv. 2017 May 18;1(13):824-834. doi: 10.1182/bloodadvances.2016002923. eCollection 2017 May 23.

5.

Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.

Roberge S, Bujold E, Nicolaides KH.

Am J Obstet Gynecol. 2018 Mar;218(3):287-293.e1. doi: 10.1016/j.ajog.2017.11.561. Epub 2017 Nov 11. Review.

PMID:
29138036
6.

Re: Risk of Cesarean scar defect following single- vs double-layer uterine closure.

Demers S, Roberge S.

Ultrasound Obstet Gynecol. 2017 Nov;50(5):667. doi: 10.1002/uog.18897. No abstract available.

PMID:
29105219
7.

Chronic hypertension: effect of blood pressure control on pregnancy outcome.

Panaitescu AM, Roberge S, Nicolaides KH.

J Matern Fetal Neonatal Med. 2017 Nov 1:1-7. doi: 10.1080/14767058.2017.1390742. [Epub ahead of print]

PMID:
28994336
8.

A cerebellar window for intravital imaging of normal and disease states in mice.

Askoxylakis V, Badeaux M, Roberge S, Batista A, Kirkpatrick N, Snuderl M, Amoozgar Z, Seano G, Ferraro GB, Chatterjee S, Xu L, Fukumura D, Duda DG, Jain RK.

Nat Protoc. 2017 Nov;12(11):2251-2262. doi: 10.1038/nprot.2017.101. Epub 2017 Oct 5.

9.

Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation.

Rolnik DL, O'Gorman N, Roberge S, Bujold E, Hyett J, Uzan S, Beaufils M, da Silva Costa F.

Ultrasound Obstet Gynecol. 2017 Nov;50(5):551-556. doi: 10.1002/uog.18899. No abstract available.

PMID:
28887883
10.

Letter to the Editor: Single- vs. Double-Layer Closure of Hysterotomy at the Time of Cesarean Delivery.

Demers S, Bujold E, Roberge S.

Ultraschall Med. 2017 Aug;38(4):448-449. doi: 10.1055/s-0043-101519. Epub 2017 Jun 14. No abstract available.

PMID:
28614856
11.

Re: Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks.

Demers S, Roberge S, Bujold E.

Ultrasound Obstet Gynecol. 2017 May;49(5):664-665. doi: 10.1002/uog.17450. No abstract available.

12.

Reporting Caesarean Delivery in Quebec Using the Robson Classification System.

Roberge S, Dubé E, Blouin S, Chaillet N.

J Obstet Gynaecol Can. 2017 Mar;39(3):152-156. doi: 10.1016/j.jogc.2016.10.010.

PMID:
28343556
13.

Single versus double-layer uterine closure at cesarean: impact on lower uterine segment thickness at next pregnancy.

Vachon-Marceau C, Demers S, Bujold E, Roberge S, Gauthier RJ, Pasquier JC, Girard M, Chaillet N, Boulvain M, Jastrow N.

Am J Obstet Gynecol. 2017 Jul;217(1):65.e1-65.e5. doi: 10.1016/j.ajog.2017.02.042. Epub 2017 Mar 3.

PMID:
28263751
14.

Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia.

Roberge S, Demers S, Bujold E.

Am J Obstet Gynecol. 2017 Jun;216(6):620-621. doi: 10.1016/j.ajog.2017.01.034. Epub 2017 Jan 29. No abstract available.

PMID:
28147242
15.

Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.

Demers S, Bujold E, Roberge S.

Obstet Gynecol. 2017 Feb;129(2):387-388. doi: 10.1097/AOG.0000000000001882. No abstract available.

PMID:
28121820
16.

Le Guide Priorité Santé.

Gagné C, Roberge S, Harvey B.

Perspect Infirm. 2016 Nov-Dec;13(5):29-31. French. No abstract available.

PMID:
29381277
17.

The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.

Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E.

Am J Obstet Gynecol. 2017 Feb;216(2):110-120.e6. doi: 10.1016/j.ajog.2016.09.076. Epub 2016 Sep 15. Review.

PMID:
27640943
18.

Heparan sulfate proteoglycans mediate renal carcinoma metastasis.

Qazi H, Shi ZD, Song JW, Cancel LM, Huang P, Zeng Y, Roberge S, Munn LL, Tarbell JM.

Int J Cancer. 2016 Dec 15;139(12):2791-2801. doi: 10.1002/ijc.30397. Epub 2016 Sep 9.

19.

Reply.

Roberge S, Demers S, Bujold E.

Am J Obstet Gynecol. 2017 Jan;216(1):83-84. doi: 10.1016/j.ajog.2016.08.001. Epub 2016 Aug 10. No abstract available.

PMID:
27521466
20.

Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction.

Roberge S, Odibo AO, Bujold E.

Clin Lab Med. 2016 Jun;36(2):319-29. doi: 10.1016/j.cll.2016.01.013. Epub 2016 Mar 8. Review.

PMID:
27235915
21.

Low-Dose Aspirin in Early Gestation for Prevention of Preeclampsia and Small-for-Gestational-Age Neonates: Meta-analysis of Large Randomized Trials.

Roberge S, Sibai B, McCaw-Binns A, Bujold E.

Am J Perinatol. 2016 Jul;33(8):781-5. doi: 10.1055/s-0036-1572495. Epub 2016 Feb 23.

PMID:
26906184
22.

Labor Dystocia and the Risk of Uterine Rupture in Women with Prior Cesarean.

Vachon-Marceau C, Demers S, Goyet M, Gauthier R, Roberge S, Chaillet N, Laroche J, Bujold E.

Am J Perinatol. 2016 May;33(6):577-83. doi: 10.1055/s-0035-1570382. Epub 2016 Jan 5.

PMID:
26731182
23.

Prevention of Preeclampsia with Aspirin in Multiple Gestations: A Systematic Review and Meta-analysis.

Bergeron TS, Roberge S, Carpentier C, Sibai B, McCaw-Binns A, Bujold E.

Am J Perinatol. 2016 May;33(6):605-10. doi: 10.1055/s-0035-1570381. Epub 2016 Jan 5. Review.

PMID:
26731178
24.

Impact of uterine closure on residual myometrial thickness after cesarean: a randomized controlled trial.

Roberge S, Demers S, Girard M, Vikhareva O, Markey S, Chaillet N, Moore L, Paris G, Bujold E.

Am J Obstet Gynecol. 2016 Apr;214(4):507.e1-507.e6. doi: 10.1016/j.ajog.2015.10.916. Epub 2015 Nov 11.

PMID:
26522861
25.

Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.

Roberge S, Demers S, Nicolaides KH, Bureau M, Côté S, Bujold E.

Ultrasound Obstet Gynecol. 2016 May;47(5):548-53. doi: 10.1002/uog.15789. Epub 2016 Apr 3. Review.

26.

An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.

Reiberger T, Chen Y, Ramjiawan RR, Hato T, Fan C, Samuel R, Roberge S, Huang P, Lauwers GY, Zhu AX, Bardeesy N, Jain RK, Duda DG.

Nat Protoc. 2015 Aug;10(8):1264-74. doi: 10.1038/nprot.2015.080. Epub 2015 Jul 23.

27.

First-Trimester Placental and Myometrial Blood Perfusion Measured by Three-Dimensional Power Doppler in Preeclampsia.

Demers S, Girard M, Roberge S, Tétu A, Giguère Y, Forest JC, Bujold E.

Am J Perinatol. 2015 Aug;32(10):920-6. doi: 10.1055/s-0034-1396686. Epub 2015 Mar 12.

PMID:
25763712
28.

Quantum dot/antibody conjugates for in vivo cytometric imaging in mice.

Han HS, Niemeyer E, Huang Y, Kamoun WS, Martin JD, Bhaumik J, Chen Y, Roberge S, Cui J, Martin MR, Fukumura D, Jain RK, Bawendi MG, Duda DG.

Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1350-5. doi: 10.1073/pnas.1421632111. Epub 2015 Jan 20. Erratum in: Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):E1048. Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):E3087.

29.

Reply: To PMID 24912096.

Bujold E, Roberge S.

Am J Obstet Gynecol. 2015 Jun;212(6):829-30. doi: 10.1016/j.ajog.2015.01.007. Epub 2015 Jan 9. No abstract available.

PMID:
25582102
30.

Ultrasonographic Evaluation of Uterine Scar Niche before and after Laparoscopic Surgical Repair: A Case Report.

Drouin O, Bergeron T, Beaudry A, Demers S, Roberge S, Bujold E.

AJP Rep. 2014 Nov;4(2):e65-8. doi: 10.1055/s-0034-1376187. Epub 2014 May 28.

31.

Low-dose aspirin for prevention of morbidity and mortality from preeclampsia.

Roberge S, Demers S, Bujold E.

Ann Intern Med. 2014 Oct 21;161(8):613. doi: 10.7326/L14-5020-4. No abstract available.

PMID:
25329210
32.

Closure of uterus and the risk of uterine rupture.

Roberge S, Bujold E.

BJOG. 2015 Oct;122(11):1542. doi: 10.1111/1471-0528.13095. Epub 2014 Oct 7. No abstract available.

33.

Uterine scar defect at 12 weeks' gestation.

Demers S, Roberge S, Girard M, Brassard N, Bujold E.

J Obstet Gynaecol Can. 2014 Sep;36(9):759. doi: 10.1016/S1701-2163(15)30472-2. English, French. No abstract available.

PMID:
25222351
34.

Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure.

Chauhan VP, Boucher Y, Ferrone CR, Roberge S, Martin JD, Stylianopoulos T, Bardeesy N, DePinho RA, Padera TP, Munn LL, Jain RK.

Cancer Cell. 2014 Jul 14;26(1):14-5. doi: 10.1016/j.ccr.2014.06.003. No abstract available.

35.

Impact of single- vs double-layer closure on adverse outcomes and uterine scar defect: a systematic review and metaanalysis.

Roberge S, Demers S, Berghella V, Chaillet N, Moore L, Bujold E.

Am J Obstet Gynecol. 2014 Nov;211(5):453-60. doi: 10.1016/j.ajog.2014.06.014. Epub 2014 Jun 6. Review.

PMID:
24912096
36.

Low-dose aspirin for the prevention of adverse pregnancy outcomes in women with elevated alpha-fetoprotein.

Demers S, Roberge S, Bujold E.

J Matern Fetal Neonatal Med. 2015 Apr;28(6):726. doi: 10.3109/14767058.2014.930428. Epub 2014 Jun 30. No abstract available.

PMID:
24893560
37.

TNF-α-mediated caspase-8 activation induces ROS production and TRPM2 activation in adult ventricular myocytes.

Roberge S, Roussel J, Andersson DC, Meli AC, Vidal B, Blandel F, Lanner JT, Le Guennec JY, Katz A, Westerblad H, Lacampagne A, Fauconnier J.

Cardiovasc Res. 2014 Jul 1;103(1):90-9. doi: 10.1093/cvr/cvu112. Epub 2014 May 6.

PMID:
24802330
38.

Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.

Bujold E, Roberge S, Nicolaides KH.

Prenat Diagn. 2014 Jul;34(7):642-8. doi: 10.1002/pd.4403. Epub 2014 May 29. Review.

PMID:
24799357
39.

Β-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?

Thireau J, Karam S, Roberge S, Roussel J, Aimond F, Cassan C, Gac A, Babuty D, Le Guennec JY, Lacampagne A, Fauconnier J, Richard S.

Heart. 2014 Jun;100(11):833-41. doi: 10.1136/heartjnl-2013-305167. Epub 2014 Mar 25.

PMID:
24667281
40.

[S. Demers et al. in reply to the article by J. Boujenah et al].

Demers S, Roberge S, Drouin O, Bujold E.

Gynecol Obstet Fertil. 2014 Mar;42(3):194-5. doi: 10.1016/j.gyobfe.2014.01.015. Epub 2014 Feb 26. French. No abstract available.

PMID:
24582207
41.

Isthmocele.

Roberge S, Demers S, Boutin A, Bujold E.

J Obstet Gynaecol Can. 2013 Dec;35(12):1069. doi: 10.1016/S1701-2163(15)30755-6. No abstract available.

PMID:
24405872
42.

Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.

Chen Y, Huang Y, Reiberger T, Duyverman AM, Huang P, Samuel R, Hiddingh L, Roberge S, Koppel C, Lauwers GY, Zhu AX, Jain RK, Duda DG.

Hepatology. 2014 Apr;59(4):1435-47. doi: 10.1002/hep.26790. Epub 2014 Feb 18.

43.

Laparoscopic repair of post-cesarean uterine scar defect.

Demers S, Roberge S, Bujold E.

J Minim Invasive Gynecol. 2013 Jul-Aug;20(4):537. doi: 10.1016/j.jmig.2013.04.010. No abstract available.

PMID:
23870243
44.

Survey on uterine closure and other techniques for Caesarean section among Quebec's obstetrician-gynaecologists.

Demers S, Roberge S, Afiuni YA, Chaillet N, Girard I, Bujold E.

J Obstet Gynaecol Can. 2013 Apr;35(4):329-333. doi: 10.1016/S1701-2163(15)30960-9.

PMID:
23660040
45.

Initiation of aspirin in early gestation for the prevention of pre-eclampsia.

Roberge S, Demers S, Bujold E.

BJOG. 2013 May;120(6):773-4. doi: 10.1111/1471-0528.12170. No abstract available.

46.

[Development of technicality indices of hysterectomies in Quebec].

Bernatchez-Laflamme SM, Bujold E, Roberge S, Laberge PY.

J Obstet Gynaecol Can. 2013 Feb;35(2):144-148. doi: 10.1016/S1701-2163(15)31019-7. French.

PMID:
23470064
47.

Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.

Snuderl M, Batista A, Kirkpatrick ND, Ruiz de Almodovar C, Riedemann L, Walsh EC, Anolik R, Huang Y, Martin JD, Kamoun W, Knevels E, Schmidt T, Farrar CT, Vakoc BJ, Mohan N, Chung E, Roberge S, Peterson T, Bais C, Zhelyazkova BH, Yip S, Hasselblatt M, Rossig C, Niemeyer E, Ferrara N, Klagsbrun M, Duda DG, Fukumura D, Xu L, Carmeliet P, Jain RK.

Cell. 2013 Feb 28;152(5):1065-76. doi: 10.1016/j.cell.2013.01.036.

48.

Risk of uterine rupture following locked vs unlocked single-layer closure.

Hudic I, Bujold E, Fatusic Z, Roberge S, Mandzic A, Fatusic J.

Med Arch. 2012;66(6):412-4.

PMID:
23409524
49.

Type 2 ryanodine receptor: a novel therapeutic target in myocardial ischemia/reperfusion.

Fauconnier J, Roberge S, Saint N, Lacampagne A.

Pharmacol Ther. 2013 Jun;138(3):323-32. doi: 10.1016/j.pharmthera.2013.01.015. Epub 2013 Feb 4. Review.

PMID:
23384595
50.

Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis.

Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E.

Ultrasound Obstet Gynecol. 2013 May;41(5):491-9. doi: 10.1002/uog.12421.

Supplemental Content

Loading ...
Support Center